This insider selling cluster is routine in size and pattern, CEO sales coincide with option exercises, and total dollar value is negligible relative to the $6.3B market cap. No bearish signal. Monitor for any material corporate events (earnings, pipeline updates) that could have prompted the option exercise timing, but the sales themselves do not warrant action.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 12 $112.41entry
- T+1 · 3mo ago −2.50%α −3.20% · $109.60
- T+5 · 3mo ago +1.15%α +1.59% · $113.70
- T+20 · 2mo ago −8.12%α −6.22% · $103.28
- T+60 · 12d ago −26.15%α −21.04% · $83.01
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Dianthus Therapeutics insiders (CEO, General Counsel, and a Director) sold a total of ~$3.2M in open-market shares over a 3-day window, with the CEO alone selling ~$15.6M including option exercises. The sales are large in absolute terms but represent only ~0.05% of the $6.3B market cap, falling below the 0.1% materiality threshold. The CEO's sales coincide with option exercises at $8.44, suggesting tax-planning or diversification rather than a bearish signal, consistent with the weak predictive power of insider sales clusters per academic literature.
Key Financial Metrics
Key Facts
- CEO Marino Garcia sold ~$15.6M in open-market shares (including option exercises at $8.44) on August 7, 2026
- General Counsel Adam Veness sold ~$1.78M on August 10, 2026
- Director Anne McGeorge sold ~$845K across multiple trades on August 10, 2026
- Total open-market sales of ~$3.2M represent ~0.05% of DNTH's $6.3B market cap
- All sales are below the 0.1% materiality threshold for insider clusters
- CEO sales coincide with exercise of deep-in-the-money options, typical of tax-motivated diversification
Financial Impact
Total insider open-market sales of ~$3.2M, or ~0.05% of market cap, immaterial relative to company size
Risk Factors
- Insider selling could accelerate if stock continues to rise, but current cluster is too small to indicate informed selling
- No material risk identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DNTH-1786485740785 |
Track record
23 reports on DNTH
7 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +41.40% at T+60 after the Jun 11, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $89.76 Now $89.55 −0.23% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $88.81 to $89.30 Now $89.55 +0.83% ▲ +0.55% −0.77% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $83.01 to $86.03 Now $89.55 +7.88% ▲ +3.64% +3.33% vs SPY
- Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
- Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $81.57 to $77.58 Now $89.55 +9.78% ▼ −4.89% −4.88% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 4/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 3/10 Viewing Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers